Supplement use during an intergroup clinical trial for breast cancer (S0221)

The use of supplements during chemotherapy is controversial, partly due to the potential effect of antioxidants on reduced efficacy of chemotherapy-related cytotoxicity. We examined supplement use among breast cancer patients registered to a clinical trial (SWOG 0221) before diagnosis and during tre...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Zirpoli, Gary R., Brennan, Patrick M., Hong, Chi-Chen, McCann, Susan E., Ciupak, Gregory, Davis, Warren, Unger, Joseph M., Thomas Budd, G., Hershman, Dawn L., Moore, Halle C.F., Stewart, James, Isaacs, Claudine, Hobday, Timothy, Salim, Muhammad, Hortobagyi, Gabriel N., Gralow, Julie R., Albain, Kathy S., Ambrosone, Christine B.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer US 2013
Gaiak:
Epidemiology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3552360/
https://ncbi.nlm.nih.gov/pubmed/23306462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-012-2400-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak